Novavax Valuation: A Closer Look at Recent Share Price Rebound and Valuation Signals

Novavax (NVAX) has experienced a 21.7% increase in share price over 7 days, a 40.5% increase over 30 days, and a 36.7% increase year-to-date. The stock's 5.7% return over the last year lags behind its peers. A Discounted Cash Flow analysis suggests an implied discount of 76.7% and indicates the shares are undervalued.